Private capital without borders: Investing in Global Life Sciences & Deeptech
Join VentureCell's next event in our Investor Breakfast series, featuring special guest speaker, Dr. Andreas Schmidt, Managing Director of Springboard Health Angels and serial biotech entrepreneur, joining us in Singapore from Munich.
Andreas will share insights on cross-border investing in healthcare, biotech and deep tech, drawing on his experience building and scaling life science companies across Asia, Europe and the United States. The discussion will explore how different forms of private capital can collaborate to finance and support innovation across borders.
Topics will include:
• Cross-border opportunities in life sciences and deep tech
• Building effective private capital syndicates
• Collaboration between angels, family offices and VCs
• The role of operational expertise in venture investing
• Lessons from financing life science companies internationally
**BONUS TOPIC**
The AI-Augmented Investor - A Better Investor?
Springboard has pioneered the use of AI across its investment workflow - from startups investor/startup matching, identifying co-investors, to analysing historical deal data and generating investment committee simulations. We'll take a behind-the-scenes look at how an angel network is applying AI in practice today.
Andreas is a former biotech CEO and founder, having led Proteona through its growth and acquisition by Singleron Biotechnologies. Today, he leads Springboard Health Angels, a network of operators, scientists, clinicians and investors supporting health and deep technology companies, with strong APAC connections.
Designed for active healthcare and life sciences investors. Attendance is subject to approval.